Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer

Frontiers in Oncology

Volumn 2 JAN, Issue , 2013, Pages

  Ahmed, Kamran A ^a   Barney, Brandon M ^b   Davis, Brian J ^b   Park, Sean S ^b   Kwon, Eugene D ^b   Olivier, Kenneth R ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Bone metastases; Intensity modulated radiation therapy; Prostate metastases; Prostate specific antigen; Stereotactic body radiation therapy; Stereotactic radiosurgery

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIANDROGEN; ASPARTATE AMINOTRANSFERASE; CHOLINE C 11; LIVER ENZYME; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BACKACHE; BONE LESION; CANCER GROWTH; CASTRATION RESISTANT PROSTATE CANCER; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DYSPNEA; EVALUATION AND FOLLOW UP; HUMAN; IMMOBILIZATION; INTENSITY MODULATED RADIATION THERAPY; MALE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROSTATE CANCER; RADIATION DOSE; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME;

EID: 84890633479     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2012.00215     Document Type: Article

References (24)

1. Ahmed, K. A., Stauder, M. C., Miller, R. C., Bauer, H. J., Rose, P. S., Olivier, K. R., et al. (2012). Stereotactic body radiation therapy in spinal metastases. Int. J. Radiat. Oncol. Biol. Phys. 82, e803-e809
2. American Cancer Society. (2010). Cancer Facts and Figures 2010. Atlanta, GA: American Cancer Society. Available at: http://www.cancer.org/acs/groups/content/@nho/documents/document/acspc-024113.pdf (accessed March 30, 2012)
3. Barney, B. M., Olivier, K. R., Macdonald, O. K., Fong de Los Santos, L. E., Miller, R. C., and Haddock, M. G. (2011). Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors. Am. J. Clin. Oncol. 35, 537-542
4. Coleman, R. E. (2001). Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat. Rev. 27, 165-176
5. Costelloe, C. M., Chuang, H. H., Madewell, J. E., and Ueno, N. T. (2010). Cancer response criteria and bone metastases: RECIST 1.1, MDA and PERCIST. J. Cancer 1, 80-92
6. Fowler, J. F., Tome, W. A., Fenwick, J. D., and Mehta, M. P. (2004). A challenge to traditional radiation oncology. Int. J. Radiat. Oncol. Biol. Phys. 15, 1241-1256
7. Hamaoka, T., Costelloe, C. M., Madewell, J. E., Liu, P., Berry, D. A., Islam, R., et al. (2010). Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer. Br. J. Cancer 102, 80-92
8. Hartsell, W. F., Scott, C. B., Bruner, D. W., Scarantino, C. W., Ivker, R. A., Roach, M. III, et al. (2005). Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J. Natl. Cancer Inst. 97, 798-804
9. Hayward, J. L., Carbone, P. P., Heusen, J. C., Heuson, J. C., Kumaoka, S., and Segaloff, A. (1977). Assessment of response to therapy in advanced breast cancer. Br. J. Cancer 35, 292-298
10. Hellerstedt, B. A., and Pienta, K. J. (2002). The current state of hormonal therapy for prostate cancer. CA Cancer J. Clin. 52, 154-179
11. Lage, M. J., Barber, B. L., Harrison, D. J., and Jun, S. (2008). The cost of treating skeletal-related events in patients with prostate cancer. Am. J. Manag. Care 14, 317-322
12. Macdonald, O. K., Kruse, J. J., Miller, J. M., Garces, Y. L., Brown, P. D., Miller, R. C., et al. (2009). Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis. Int. J. Radiat. Oncol. Biol. Phys. 75, 950-958
13. Mahadevan, A., Floyd, S., Wong, E., Jeyapalan, S., Groff, M., and Kasper, E. (2011). Stereotactic body radiotherapy reirradiation for recurrent epidural spinal metastases. Int. J. Radiat. Oncol. Biol. Phys. 81, 1500-1505
14. Muacevic, A., Kufeld, M., Rist, C., Wowra, B., Stief, C., and Staehler, M. (2011). Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer. Urol. Oncol. doi: 10.1016/j.urolonc.2011.02.023 [Epub ahead of print]
15. National Cancer Institute. (2006). Cancer Therapy Evaluation Program. Available at: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf (accessed March 30, 2012)
16. Okunieff, P., Petersen, A. L., Philip, A., Milano. M. T., Katz, A. W., Boros, L., et al. (2006). Stereotactic body radiation therapy (SBRT) for lung metastases. Acta Oncol. 45, 808-817
17. Sahgal, A., Ames, C., Chou, D., Ma, L., Huang, K., Xu, W., et al. (2009). Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases. Int. J. Radiat. Oncol. Biol. Phys. 74, 723-731
18. Salama, J. K., Chmura, S. J., Mehta, N., Yenice, K. M., Stadler, W. M., Vokes, E. E., et al. (2008). An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease. Clin. Cancer Res. 14, 5255-5259
19. Sandler, H. M., Dunn, R. L., McLaughlin, P. W., Hayman, J. A., Sullivan, M. A., and Taylor, J. M. (2000). Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 48, 629-633
20. Smith, M. R., Kabbinavar, F., Saad, F., Hussain, A., Gittelman, M. C., Bilhartz, D. L., et al. (2005). Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer. J. Clin. Oncol. 23, 2918-2925
21. Stauder, M. C., Macdonald, O. K., Olivier, K. R., Call, J. A., Lafata, K., Mayo, C. S., et al. (2011). Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions. Radiother. Oncol. 99, 166-171
22. Weinfurt, K. P., Li, Y., Castel, L. D., Saad, F., Timbie, J. W., Glendenning, G. A., et al. (2002). The impact of skeletal-related events on health-related quality of life of patients with metastatic prostate cancer. Ann. Oncol. 13(Suppl. 5), 180 (abstract)
23. WHO. (1979). WHO Handbook for Reporting Results of Cancer Treatment. Geneva: World Health Organization Offset Publication
24. Yamada, Y., Bilsky, M. H., Lovelock, D. M., Venkatraman, E. S., Toner, S., Johnson, J., et al. (2008). High-dose, single fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int. J. Radiat. Oncol. Biol. Phys. 71, 484-490